SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients.
Antonsen SL, Loft A, Fisker R, Nielsen AL, Andersen ES, Høgdall E, Tabor A, Jochumsen K, Fagö-Olsen CL, Asmussen J, Berthelsen AK, Christensen IJ, Høgdall C.
Antonsen SL, et al. Among authors: fago olsen cl.
Gynecol Oncol. 2013 May;129(2):298-303. doi: 10.1016/j.ygyno.2013.01.019. Epub 2013 Jan 29.
Gynecol Oncol. 2013.
PMID: 23376805
Clinical Trial.